Literature DB >> 16047267

Case for folic acid and vitamin B12 fortification in Europe.

Sébastien Czernichow1, Nathalie Noisette, Jacques Blacher, Pilar Galan, Louise Mennen, Serge Hercberg, Pierre Ducimetière.   

Abstract

The number of pregnancies affected by neural tube defects has been estimated to be 4000/year in Europe, with a higher prevalence in Celtic populations and in women of low socioeconomic status. Since the 1980s, it has been shown that supplementation with folic acid during the periconceptual period reduces the risk of neural tube defects in the fetus. However, in view of the period during which supplementation should be taken (< 4 weeks before conception until 8-10 weeks after) and the fact that in some countries 30-50% of pregnancies are unplanned, a public health initiative based solely on increasing dietary folate intake or recommendations on use of folic acid supplements is likely to be insufficient. Mandatory fortification has been started in 38 countries throughout the world. Several European countries have advocated mandatory flour folic acid fortification over the last 6 years, but none has introduced it. A recent public health decision in Hungary stimulated flour fortification on a voluntary basis, but it remains the only European country to take this action. Many European countries have deferred a decision to introduce fortification because of concerns about possible masking of vitamin B (12) deficiency. This review advocates a proposal for combined fortification of folic acid and vitamin B (12) to address possible hazards of fortification with folic acid alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047267     DOI: 10.1055/s-2005-872400

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  5 in total

1.  Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.

Authors:  Antonia M Fernández-Peralta; Lydia Daimiel; Nargisse Nejda; Daniel Iglesias; Vicente Medina Arana; Juan J González-Aguilera
Journal:  Int J Colorectal Dis       Date:  2009-08-11       Impact factor: 2.571

2.  Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability.

Authors:  Luciano Delgado-Plasencia; Vicente Medina-Arana; Alberto Bravo-Gutiérrez; Julián Pérez-Palma; Hugo Álvarez-Argüelles; Eduardo Salido-Ruiz; Antonia M Fernández-Peralta; Juan J González-Aguilera
Journal:  Int J Colorectal Dis       Date:  2013-02-20       Impact factor: 2.571

Review 3.  Factors contributing to the success of folic acid public health campaigns.

Authors:  D Rofail; A Colligs; L Abetz; M Lindemann; L Maguire
Journal:  J Public Health (Oxf)       Date:  2011-07-03       Impact factor: 2.341

4.  Population prevalence, attributable risk, and attributable risk percentage for high methylmalonic acid concentrations in the post-folic acid fortification period in the US.

Authors:  Vijay Ganji; Mohammad R Kafai
Journal:  Nutr Metab (Lond)       Date:  2012-01-11       Impact factor: 4.169

5.  Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region.

Authors:  Haochen Wang; Hans De Steur; Gong Chen; Xiaotian Zhang; Lijun Pei; Xavier Gellynck; Xiaoying Zheng
Journal:  Nutrients       Date:  2016-03-09       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.